Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production

K. Horie, H. Miyazaki, T. Hagiwara, E. Tahara, A. Matsumoto, T. Kadoya, K. Ogami, Takashi Kato

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Formation of proplatelets from megakaryocytes is believed to be the first step of platelet production in vitro. In this study, we evaluated the effects of recombinant human thrombopoietin (hTPO) on the development of proplatelets from a GpIIb/IIIa+ population of rat bone marrow cells highly enriched for late megakaryocyte progenitors (GpIIb/IIIa+ CFU-MK) that we recently found to be a primary target population of TPO. Quantitative measurement of hTPO-induced proplatelet formation was performed in liquid cultures. Proplatelet formation from megakaryocytes derived from GpIIb/IIIa+ CFU-MK in the presence of hTPO began on day 4 of culture and peaked the following day. On day 5 of culture, lower concentrations of hTPO expanded the number of megakaryocytes, increased the number of proplatelets and the percentage of proplatelet-developing megakaryocytes. Increasing hTPO concentrations resulted in a modest decrease in proplatelet development. We next used hTPO to derive immature or mature megakaryocytes from GpIIb/IIIa+ CFU-MK. These populations of cultured megakaryocytes spontaneously formed proplatelets when recultured in the absence of exogenous hTPO. The addition of hTPO at higher concentrations modestly augmented proplatelet production from immature megakaryocytes derived from 2-day liquid cultures. However, either murine interleukin-6 (IL-6) or human IL-11, but not rat IL-3, was more potent than hTPO in augmenting proplatelet formation from immature megakaryocytes. Each of these four cytokines had an inhibitory effect on proplatelet formation from more differentiated megakaryocytes derived from 3-day liquid cultures. These results indicate that TPO enhances proplatelet production primarily by stimulating CFU-MK to increase the number of proplatelet-forming megakaryocytes and that its action is clearly different from those of other cytokines that also stimulate megakaryocytopoiesis.

Original languageEnglish
Pages (from-to)169-176
Number of pages8
JournalExperimental Hematology
Volume25
Issue number2
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Megakaryocyte Progenitor Cells
Thrombopoietin
Megakaryocytes
Interleukin-11
Cytokines
Thrombopoiesis
Interleukin-3
Health Services Needs and Demand
Bone Marrow Cells
Population
Interleukin-6
Blood Platelets

Keywords

  • GpIIb/IIIa
  • megakaryocyte
  • megakaryocyte progenitor cell
  • proplatelet
  • thrombopoietin

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Horie, K., Miyazaki, H., Hagiwara, T., Tahara, E., Matsumoto, A., Kadoya, T., ... Kato, T. (1997). Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Experimental Hematology, 25(2), 169-176.

Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. / Horie, K.; Miyazaki, H.; Hagiwara, T.; Tahara, E.; Matsumoto, A.; Kadoya, T.; Ogami, K.; Kato, Takashi.

In: Experimental Hematology, Vol. 25, No. 2, 1997, p. 169-176.

Research output: Contribution to journalArticle

Horie, K, Miyazaki, H, Hagiwara, T, Tahara, E, Matsumoto, A, Kadoya, T, Ogami, K & Kato, T 1997, 'Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production', Experimental Hematology, vol. 25, no. 2, pp. 169-176.
Horie K, Miyazaki H, Hagiwara T, Tahara E, Matsumoto A, Kadoya T et al. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Experimental Hematology. 1997;25(2):169-176.
Horie, K. ; Miyazaki, H. ; Hagiwara, T. ; Tahara, E. ; Matsumoto, A. ; Kadoya, T. ; Ogami, K. ; Kato, Takashi. / Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. In: Experimental Hematology. 1997 ; Vol. 25, No. 2. pp. 169-176.
@article{14a4f2b17f0b4cb8b29082885e758296,
title = "Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production",
abstract = "Formation of proplatelets from megakaryocytes is believed to be the first step of platelet production in vitro. In this study, we evaluated the effects of recombinant human thrombopoietin (hTPO) on the development of proplatelets from a GpIIb/IIIa+ population of rat bone marrow cells highly enriched for late megakaryocyte progenitors (GpIIb/IIIa+ CFU-MK) that we recently found to be a primary target population of TPO. Quantitative measurement of hTPO-induced proplatelet formation was performed in liquid cultures. Proplatelet formation from megakaryocytes derived from GpIIb/IIIa+ CFU-MK in the presence of hTPO began on day 4 of culture and peaked the following day. On day 5 of culture, lower concentrations of hTPO expanded the number of megakaryocytes, increased the number of proplatelets and the percentage of proplatelet-developing megakaryocytes. Increasing hTPO concentrations resulted in a modest decrease in proplatelet development. We next used hTPO to derive immature or mature megakaryocytes from GpIIb/IIIa+ CFU-MK. These populations of cultured megakaryocytes spontaneously formed proplatelets when recultured in the absence of exogenous hTPO. The addition of hTPO at higher concentrations modestly augmented proplatelet production from immature megakaryocytes derived from 2-day liquid cultures. However, either murine interleukin-6 (IL-6) or human IL-11, but not rat IL-3, was more potent than hTPO in augmenting proplatelet formation from immature megakaryocytes. Each of these four cytokines had an inhibitory effect on proplatelet formation from more differentiated megakaryocytes derived from 3-day liquid cultures. These results indicate that TPO enhances proplatelet production primarily by stimulating CFU-MK to increase the number of proplatelet-forming megakaryocytes and that its action is clearly different from those of other cytokines that also stimulate megakaryocytopoiesis.",
keywords = "GpIIb/IIIa, megakaryocyte, megakaryocyte progenitor cell, proplatelet, thrombopoietin",
author = "K. Horie and H. Miyazaki and T. Hagiwara and E. Tahara and A. Matsumoto and T. Kadoya and K. Ogami and Takashi Kato",
year = "1997",
language = "English",
volume = "25",
pages = "169--176",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production

AU - Horie, K.

AU - Miyazaki, H.

AU - Hagiwara, T.

AU - Tahara, E.

AU - Matsumoto, A.

AU - Kadoya, T.

AU - Ogami, K.

AU - Kato, Takashi

PY - 1997

Y1 - 1997

N2 - Formation of proplatelets from megakaryocytes is believed to be the first step of platelet production in vitro. In this study, we evaluated the effects of recombinant human thrombopoietin (hTPO) on the development of proplatelets from a GpIIb/IIIa+ population of rat bone marrow cells highly enriched for late megakaryocyte progenitors (GpIIb/IIIa+ CFU-MK) that we recently found to be a primary target population of TPO. Quantitative measurement of hTPO-induced proplatelet formation was performed in liquid cultures. Proplatelet formation from megakaryocytes derived from GpIIb/IIIa+ CFU-MK in the presence of hTPO began on day 4 of culture and peaked the following day. On day 5 of culture, lower concentrations of hTPO expanded the number of megakaryocytes, increased the number of proplatelets and the percentage of proplatelet-developing megakaryocytes. Increasing hTPO concentrations resulted in a modest decrease in proplatelet development. We next used hTPO to derive immature or mature megakaryocytes from GpIIb/IIIa+ CFU-MK. These populations of cultured megakaryocytes spontaneously formed proplatelets when recultured in the absence of exogenous hTPO. The addition of hTPO at higher concentrations modestly augmented proplatelet production from immature megakaryocytes derived from 2-day liquid cultures. However, either murine interleukin-6 (IL-6) or human IL-11, but not rat IL-3, was more potent than hTPO in augmenting proplatelet formation from immature megakaryocytes. Each of these four cytokines had an inhibitory effect on proplatelet formation from more differentiated megakaryocytes derived from 3-day liquid cultures. These results indicate that TPO enhances proplatelet production primarily by stimulating CFU-MK to increase the number of proplatelet-forming megakaryocytes and that its action is clearly different from those of other cytokines that also stimulate megakaryocytopoiesis.

AB - Formation of proplatelets from megakaryocytes is believed to be the first step of platelet production in vitro. In this study, we evaluated the effects of recombinant human thrombopoietin (hTPO) on the development of proplatelets from a GpIIb/IIIa+ population of rat bone marrow cells highly enriched for late megakaryocyte progenitors (GpIIb/IIIa+ CFU-MK) that we recently found to be a primary target population of TPO. Quantitative measurement of hTPO-induced proplatelet formation was performed in liquid cultures. Proplatelet formation from megakaryocytes derived from GpIIb/IIIa+ CFU-MK in the presence of hTPO began on day 4 of culture and peaked the following day. On day 5 of culture, lower concentrations of hTPO expanded the number of megakaryocytes, increased the number of proplatelets and the percentage of proplatelet-developing megakaryocytes. Increasing hTPO concentrations resulted in a modest decrease in proplatelet development. We next used hTPO to derive immature or mature megakaryocytes from GpIIb/IIIa+ CFU-MK. These populations of cultured megakaryocytes spontaneously formed proplatelets when recultured in the absence of exogenous hTPO. The addition of hTPO at higher concentrations modestly augmented proplatelet production from immature megakaryocytes derived from 2-day liquid cultures. However, either murine interleukin-6 (IL-6) or human IL-11, but not rat IL-3, was more potent than hTPO in augmenting proplatelet formation from immature megakaryocytes. Each of these four cytokines had an inhibitory effect on proplatelet formation from more differentiated megakaryocytes derived from 3-day liquid cultures. These results indicate that TPO enhances proplatelet production primarily by stimulating CFU-MK to increase the number of proplatelet-forming megakaryocytes and that its action is clearly different from those of other cytokines that also stimulate megakaryocytopoiesis.

KW - GpIIb/IIIa

KW - megakaryocyte

KW - megakaryocyte progenitor cell

KW - proplatelet

KW - thrombopoietin

UR - http://www.scopus.com/inward/record.url?scp=0031057949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031057949&partnerID=8YFLogxK

M3 - Article

C2 - 9015217

AN - SCOPUS:0031057949

VL - 25

SP - 169

EP - 176

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 2

ER -